Inhibition of OLIG2 activity
US10227333B2 · kind B2 · utility
3Cited by
76References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2016 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Feb 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.